- In March 2024, A team from Tokyo University of Science (TUS) has developed a groundbreaking flexible paper-based AI health sensor. This innovative device integrates nanocellulose and zinc oxide (ZnO) nanoparticles to deliver real-time optical input, offering significant potential in health monitoring technologies due to its flexibility, lightweight design, and advanced sensing capabilities
- In January 2024, Medtronic plc, a global leader in healthcare innovation, has announced the CE (Conformité Européenne) mark approval for its MiniMed 780G system with Simplera Sync. This system introduces a disposable, all-in-one continuous glucose monitor (CGM) that eliminates the need for over-tape or finger sticks, providing seamless diabetes management and enhanced patient comfort
- In January 2024, Inspira Technologies OXY B.H.N Ltd., known for pioneering life support technologies, revealed plans to launch a single-use disposable blood oxygenation kit. This kit, currently under development for the INSPIRA ART medical device series, aims to revolutionize respiratory support by providing efficient and portable oxygenation solutions for critical care patients
- In June 2021, OMNIVISION Technologies, Inc. unveiled the first 8-megapixel (MP) resolution sensors designed for both reusable and single-use endoscopes. These sensors, offering enhanced imaging quality, support medical applications outside the visible spectrum, marking a significant advancement in medical imaging. The new OH08B sensor boosts the capability of endoscopes and promises to expand market opportunities
- In February 2021, Hill-Rom made a strategic acquisition by paying EarlySense USD 30 million for its contactless continuous monitoring technology. With a focus on advancing remote patient care, this acquisition strengthens Hill-Rom’s portfolio, enabling the company to integrate next-generation AI-based sensing technologies into its healthcare solutions, improving patient outcomes and care efficiency
- In 2021, Abbott received FDA Emergency Use Authorization (EUA) for its BinaxNOW COVID-19 AG self-test. This over-the-counter, non-prescription test allows asymptomatic individuals to detect COVID-19 infections easily and quickly, revolutionizing testing accessibility. The rapid and user-friendly nature of this self-test has contributed significantly to global pandemic management efforts
- In 2020, Medtronic received FDA approval for its MiniMed 770G hybrid closed-loop system, which includes the Guardian Sensor 3 and the MiniMed Mobile app. This system provides continuous glucose monitoring, enabling real-time adjustments to insulin delivery. It enhances diabetes management by reducing the burden of constant monitoring and helping maintain stable blood sugar levels
- In May 2020, Philips introduced a next-generation wearable biosensor designed for clinical COVID-19 surveillance. This small, disposable biosensor, worn as a patch for five days, is capable of continuously monitoring patient health indicators. It connects to a scalable hub that allows healthcare providers to monitor multiple patients simultaneously, enhancing early detection and patient deterioration identification
